Revenue | $10 - $100 million See Exact Annual Revenue |
---|---|
Employees | 100 - 500Exact Company Size |
Primary Industry | 5416 Management, Scientific & Technical Consulting Services |
Additional NAICS Codes | 334516 Analytical Laboratory Instrument Manufacturing |
Address | 401 N Broad St Ste 222 Philadelphia, PA 19108 |
Biomeme | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $10 - $100 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
Biomeme P&L | $ Millions |
---|---|
Revenue (Sales) | ![]() |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
XCEL Medical diagnostic test kits; medical diagnostic test kits for human and veterinary use; medical diagnostic test kits, namely, Isothermal test kits; molecular medical diagnostic test kits consisting of a test panel for rapidly diagnosing sexually transmitted diseases and infections; molecular medical diagnostic test kits consisting of a respiratory panel for rapidly diagnosing respiratory illness, namely, sars-cov-2 and influenza; molecular testing reagents for medical use; diagnostic test kits comprised of medical respiratory panels and assays for testing of respiratory illness, namely, sars-cov-2 and influenza; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sars-cov-2 and influenza | 06/29/2022 |
PREDIGEN Diagnostic testing materials, diagnostic preparations for medical testing purposes, diagnostic preparations, and diagnostic reagents all for the detection and diagnosis of Covid-19; diagnostic testing materials for the detection and diagnosis of viral, bacterial and fungal infections, sepsis, cardiovascular disease, radiation exposure, autoimmune and inflammatory disease and cancer | 03/16/2022 |
BIOMEME Molecular diagnostics apparatus, namely, computer software, computer programs, computer firmware, web applications and associated instruction manuals all for use in controlling processes, inputting, amplifying, detecting, identifying, analyzing, modifying, transferring, displaying, mapping, reporting and storing molecular diagnostic and surveillance data and results for scientific and research purposes | 10/07/2012 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
LCP HAMPTON BEACH HOSPITALITY | Plymouth, MA | 100 |
BOOZ ALLEN HAMILTON | Mclean, VA | 16 |
ACCENTURE | Chicago, IL | 14 |
MCKINSEY | New York, NY | 12 |
DELAWARE NORTH COMPANIES | Buffalo, NY | 6 |
ATLAS TECHNOLOGY SOLUTIONS | Chicago, IL | 5 |
MAXIMUS SERVICES | Mclean, VA | 5 |
WILLIS TOWERS WATSON US | Arlington, VA | 4 |
KBR HOLDINGS | Houston, TX | 3 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
TINUITI | Philadelphia, PA | 100 |
HILL INTERNATIONAL | Philadelphia, PA | 85 |
G. F. MANAGEMENT | Philadelphia, PA | 53 |
HKA GLOBAL | Philadelphia, PA | 33 |
SNIDER ENTITIES | Philadelphia, PA | 28 |
BIOMEME | Philadelphia, PA | 27 |
Company | Revenue ($ MM) |
---|---|
![]() |